眼底病治疗

Search documents
爱尔眼科股价上涨1.30% 公司积极拓展老花治疗业务
Sou Hu Cai Jing· 2025-08-18 16:36
资金方面,8月18日主力资金净流入4784.89万元,近五日主力资金净流出3.04亿元。 风险提示:市场有风险,投资需谨慎。 来源:金融界 截至2025年8月18日收盘,爱尔眼科股价报13.22元,较前一交易日上涨1.30%。当日成交额达18.43亿 元,成交量139.93万手,振幅2.30%。 爱尔眼科属于医疗服务板块,是一家专注于眼科医疗服务的连锁医疗机构,业务涵盖近视矫正、白内障 手术、眼底病治疗等多个领域。公司通过国内外市场布局,持续扩大医疗服务网络。 公司在互动平台表示,目前国内老花治疗普及率较低,但欧洲子公司在该领域经验丰富,业务发展良 好。为适应老龄化需求,公司已在多地医院开设老视门诊,并计划成立老视学组,推动相关诊疗业务发 展。 ...
股市必读:普瑞眼科(301239)5月8日董秘有最新回复
Sou Hu Cai Jing· 2025-05-08 17:52
Core Viewpoint - As of May 8, 2025, the stock price of Puri Eye Hospital (301239) closed at 43.0 yuan, reflecting a decrease of 1.17% with a turnover rate of 2.33% and a trading volume of 16,500 shares, amounting to a transaction value of 71.48 million yuan [1]. Group 1: Business Operations - Puri Eye Hospital operates as a large-scale non-public ophthalmology specialty medical group, with all its hospitals included in the medical insurance designated point system [2]. - The company has a dual pricing logic for its products and services: it has full pricing autonomy for selective consumer projects and high-end examinations (outside the medical insurance catalog), while it strictly adheres to national medical insurance cost control policies for basic treatments and routine examinations (within the medical insurance catalog) [2]. - The company is leveraging the benefits of medical insurance cost control policies, such as centralized procurement price reductions and optimized payment methods, to enhance the accessibility and affordability of eye disease treatments for patients [2]. Group 2: Financial Flow - On May 8, 2025, the financial flow for Puri Eye Hospital showed a net outflow of 3.06 million yuan from major funds and a net outflow of 2.09 million yuan from speculative funds, while retail investors saw a net inflow of 5.15 million yuan [2].